Abbey Applemax Gold [size: 120ml]
Apple flavour liquid broad spectrum wormer and boticide for horses - your horse will taste the difference!
Active ConstituentS: 75mg/mL PRAZIQUANTEL, 10mg/mL IVERMECTIN (Similar to Imax Gold)
For treatment and control of tapeworms, large strongyles, small strongyles, hairworms, pinworms, roundworms (ascarids), intestinal threadworms, large mouthed stomach worms, bots, lungworms, summer sores and cutaneous onchocerciasis.
• Targeted dosing
• Apple flavoured
• Low dose volume
• Each 120ml bottle treats 10 x 600kg horses
• Dosing syringe/applicator included
• Safe to use in ALL horses
• Cost effective
DOSAGE AND ADMINISTRATION
Discard any unused diluted APPLEMAX™ GOLD LIQUID WORMER suspension 24 hours after dilution. The recommended dose is 1mL APPLEMAX™ GOLD LIQUID WORMER per 50kg liveweight (equivalent to 200µg Ivermectin per kilogram liveweight and 1.5mg Praziquantel per kilogram liveweight).
APPLEMAX™ GOLD LIQUID WORMER can be given as an oral drench or by stomach tube (nasogastric intubation). Nasogastric intubation should only be done by a veterinarian or under veterinary supervision.
Administration as an oral drench: For administration by this method, an undiluted dose is usually preferred. Clear the horse’s mouth of any food material, elevate the horse’s head, and using a suitable dosing syringe, deposit the appropriate dose in the back of the mouth. In order to avoid unnecessary coughing or the potential for material to enter the trachea and lungs, do not use excessive pressure, do not use a large dose volume of diluted APPLEMAX™ GOLD LIQUID WORMER, and do not deposit the dose in the laryngeal area. Increased dose rejection may occur if the dose is deposited in the front of the mouth. Keep the horse’s head elevated and observe the horse to ensure the dose is retained.
Size 120ml with syringe
(ABL-AG)
| SKU | ABL-AG |
| Brand | Abbey Labs |
Be The First To Review This Product!
Help other Equine Performance users shop smarter by writing reviews for products you have purchased.
